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Abstract: Constrictive bronchiolitis obliterans is a fibrotic disease of small airways 
characterized by progressive obliteration of the airway lumen, with resulting obstructive 
pulmonary physiology. While previous work has demonstrated the collagenous nature of the 
constrictive ﬁ  brotic lesions, elastin expression in the disease has been poorly characterized. 
Elastin is a critical component of the pulmonary extracellular matrix, and is responsible for the 
reversible deformability characteristic of the alveoli, pulmonary blood vessels, and airways. 
Elastin is a long-lived protein with virtually no active protein production occurring after lung 
development is completed during early childhood. We report a novel case of cryptogenic 
bronchiolitis obliterans in which elastin gene expression is actively upregulated in affected 
airways, and accompanied by myoﬁ  broblast hyperplasia and disorganized elastic ﬁ  ber depo-
sition. In addition, deposition of new elastic ﬁ  bers by myoﬁ  broblasts is noted in the alveoli 
surrounding the affected bronchioles.
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Introduction
Constrictive bronchiolitis obliterans (CBO) is a ﬁ  brotic lung disease primarily affecting 
the small (3 mm diameter) conducting airways of the lungs (Couture and Colby 2003). 
“Constrictive” bronchiolitis obliterans was ﬁ  rst used as a descriptive term in 1973 
(Gosink et al 1973), and describes a ﬁ  brosing inﬂ  ammatory process that surrounds, 
rather than ﬁ  lls, the airway lumen (Colby 1998). This process results in extrinsic air-
way compression and luminal obliteration. CBO is rare in adults, and has been poorly 
studied. In most cases, the etiologic agent associated with CBO is known, although 
the evidence underlying some of these associations is tenuous (Ryu et al 2003). The 
term “cryptogenic obliterative bronchiolitis” was ﬁ  rst used in 1981 to characterize 
cases of otherwise unexplained progressive airﬂ  ow obstruction (Turton et al 1981). 
A small number of pathologically conﬁ  rmed cryptogenic cases of CBO have however 
been documented (Kraft et al 1993).
The bronchioles are a physiologically silent area of the lung as a result of their 
considerable cross-sectional area. The diameter of each successive distal airway 
generation decreases progressively from the tracheal division onward. However, the 
resulting total cross-sectional luminal area increases with each successive airway 
generation, a feature that attains the most signiﬁ  cance in the conducting airways 
distal to the origin of the bronchioles (Baraldo et al 2003). Thus, extensive damage to 
the bronchioles may result in considerable pathophysiologic consequences. In CBO, 
where progressive obliteration of bronchioles leads to decreased conducting airway 
cross-sectional area, concomitant obstructive physiology develops that is complicated 
by air-trapping and hyperinﬂ  ation.
Elastic ﬁ  bers are composite structures containing two primary morphologi-
cally distinguishable components, elastin and microﬁ  brils (reviewed in Kielty et al International Journal of COPD 2007:2(4) 594
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(2002)). Elastin, a major elastic ﬁ  ber component, is known 
to be essential for lung development and mechanical func-
tion (Mariani et al 1997), and elastic ﬁ  bers are distributed 
throughout the lung, including the alveoli, airways, vessels 
and pleura. The rate of lung elastin synthesis is greatest dur-
ing fetal and neonatal development, but is almost undetect-
able in healthy adult lung (Mariani et al 2002). However, in 
pathological circumstances such as emphysema or pulmonary 
ﬁ  brosis, there may be reactivation of elastin expression in the 
adult lung leading to excessive or aberrant elastin deposition 
(Snider et al 1991; Lucey et al 1998; Hoff et al 1999). Func-
tional ﬁ  ber formation requires coordinated re-expression of 
all ﬁ  ber components in a temporally and spatially regulated 
sequence. This is assumed to be an inefﬁ  cient process in 
adult tissue, as re-initiated elastin deposition in injured adult 
tissues is often characterized by faulty organization of the 
newly formed three-dimensional ﬁ  ber.
CBO predominantly affects small airways, with few or 
no histologic changes observed in the alveoli surrounding 
the diseased airways (Couture and Colby 2003). Given that 
CBO involves both airway injury and a ﬁ  brotic response, 
the ﬁ  nding of increased production of extracellular matrix 
components in the airways would not be surprising. While 
previous work has conﬁ  rmed the presence of extensive 
collagenous fibrosis in the walls of bronchi with CBO 
(Markopoulo et al 2002), elastin gene expression and protein 
deposition have been poorly characterized. Here, we report a 
case of cryptogenic bronchiolitis obliterans in which elastin 
expression and deposition are markedly and pathologically 
increased, not only in the affected bronchioles, but also in 
the surrounding alveoli.
Case report
A 63-year-old man with a 5-month history of progressive 
dyspnea, cough, and scant sputum production was referred 
for pulmonary evaluation. Prior to the onset of dyspnea he 
was fully functional without exercise limitation. Onset of 
his symptomatology was coincident with the development 
of an upper respiratory infection. Outpatient therapy with 
antibiotics and bronchodilators had resulted in a minimal 
but temporary improvement. At presentation, the patient was 
dyspneic with showering and climbing any stairs. Social his-
tory was remarkable for a 5-year history of cigar smoking, 
which he discontinued 25-years prior to referral. Extensive 
questioning did not yield any signiﬁ  cant history of occupa-
tional or environmental exposures, and family history was 
non-contributory for pulmonary disease. The patient had a 
history of a thymoma, but testing revealed no evidence of 
myasthenia gravis or any other systemic manifestations of 
thymic disease. CXR was signiﬁ  cant for bilateral hyperinﬂ  a-
tion, without evidence of emphysema. CT scan again demon-
strated marked hyperinﬂ  ation with little evidence to suggest 
emphysema. Bilateral bronchiectasis and bronchiolitis with 
lower lobe predominance were evident. Extensive workup 
for causes of secondary bronchiectasis was unremarkable. 
Spirometry conﬁ  rmed a partially reversible severe obstructive 
ventilatory defect, with an FEV1 = 0.67L (19% predicted) 
an FVC = 2.17L (48% predicted), and an FEV1: FVC ratio 
of 39%. Lung volumes revealed no hyperinﬂ  ation with a 
TLC = 7.84L (109% predicted), but air trapping was signiﬁ  cant 
with an RV = 5.28L (222% predicted). Resting ABG showed 
pH = 7.38, PaCO2 = 54, and PaO2 = 50 on room air, with a 
room-air SpO2 of 88%. Six-minute walk testing demonstrated 
that the patient required supplemental oxygen at 2 L/min at rest 
and 3 L/min with activity to maintain an SpO2  90%. Despite 
aggressive therapy with oxygen, bronchodilators, intermittent 
antibiotics, anti-inﬂ  ammatories (corticosteroids and macro-
lides), and rehabilitation, his disease continued to progress. 
Due to his severe clinical and physiologic impairments the 
patient was evaluated and listed for lung transplantation. 
Bilateral sequential lung transplantation was performed 
3-months later without complication. At the time of surgery, 
the lungs were noted to be grossly hyperinﬂ  ated, and did not 
deﬂ  ate after resection and removal from the thorax. An explant 
wedge biopsy sent for pathologic examination revealed the 
diagnosis of constrictive bronchiolitis obliterans, which on 
the basis of his clinical history was considered cryptogenic in 
etiology. The rest of the lung was placed in storage at −80 °C 
for further study. At the time of writing, the patient continues 
to do well 15 months after transplantation.
Methods and materials
Lung processing
The explanted diseased lung was kept on ice during sampling, 
as was a donor lung rejected for transplantation that was 
used as a tissue control. Portions of peripheral lung 1 cm2 
were excised with a scalpel and ﬁ  xed without inﬂ  ation in 4% 
paraformaldehyde overnight at 4 °C before parafﬁ  n embed-
ding. Serial 5 μm-thick sections were cut, deparafﬁ  nized, 
and stained with hematoxylin and eosin (H and E). Identical 
sections were used for Hart’s staining, in-situ hybridization 
and immunohistologic staining.
Hart’s elastin staining
Peripheral CBO and control lung tissue sections (5 μm) 
embedded in parafﬁ  n were deparafﬁ  nized and re-hydrated International Journal of COPD 2007:2(4) 595
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through graded ethanol to PBS, then soaked in 0.25% 
potassium permanganate solution for 5 minutes. Slides were 
cleared in 5% oxalic acid and soaked in resorcin-fuchsin 
solution (Poly Scientiﬁ  c, Bay Shore, NY, USA) overnight. 
After washing in water, sections were counterstained with 
tartrazine (yellow), dehydrated through graded ethanol, 
cleared in xylene and mounted.
Smooth muscle actin 
immunohistochemistry
Sections of parafﬁ  n embedded peripheral CBO and control 
lung were deparafﬁ  nized in xylene, then re-hydrated in a 
descending ethanol series and allowed to stand in PBS for 
10 minutes. Slides were blocked for 1 hour with 10% fetal 
horse serum, rinsed in PBS, then incubated overnight at 4 ºC 
with the primary alpha smooth muscle actin (α-SMA) antibody 
(1A4 mouse monoclonal, 1:200 dilution, Sigma, St. Louis, 
MO, USA). After rinsing in PBS, sections were incubated 
in the dark with secondary antibody (ﬂ  uorescein-conjugated 
goat anti-mouse IgG, 1:250 dilution, 1 hour, room tempera-
ture, Jackson ImmunoResearch, Westgrove, PA). Following 
rinsing in PBS, sections were cover slipped using Vectashield 
mounting medium (Vector Laboratories, Burlingame, CA) and 
viewed under ﬂ  uorescent light for image capture.
In situ hybridization
Digoxygenin-labeled antisense and sense riboprobes were 
generated from a baboon tropoelastin cDNA that had been 
linearized for in vitro transcription (Promega, Madison, WI, 
USA). Sections of parafﬁ  n embedded peripheral CBO and 
control lung were deparafﬁ  nized, re-hydrated and digested 
with proteinase K. The tissue sections were blocked with 
triethanolamine and acetic anhydride, then hybridized with 
denatured digoxygenin-labeled riboprobe overnight at 60 °C. 
Following hybridizations, tissue sections were subjected to a 
series of washes including digestion with RNase A, treated 
with blocking agents, and incubated with an antibody conju-
gated to alkaline phosphatase. After additional washes, slides 
were incubated with a chromogen substrate for 1–3 days. 
After color development, specimens were counterstained 
with nuclear fast red.
Results
Initial analysis of the CBO lung
The explanted lung remained inﬂ  ated after resection and was 
ﬁ  rm to the touch. When tissue specimens of approximately 
1 cm3 were cut from the periphery of the lung, these too 
remained inﬂ  ated. Gross examination showed no obvious 
emphysematous changes within peripheral tissue sections. 
Staining with hematoxylin and eosin (H and E) showed that 
the peripheral tissue had few bronchioles, but no evidence of 
emphysema, conﬁ  rming the CXR, CT and formal pathologic 
ﬁ  ndings. Inﬂ  ammatory inﬁ  ltrates were present adjacent to 
large airways paralleling intralobar arteries. Some particulate 
deposits were associated with the inﬂ  ammatory inﬁ  ltrates 
(Figure 1, arrowheads).
Excess elastic ﬁ  ber deposition 
and mRNA expression
Because the lung exhibited unusual mechanical properties, 
did not deﬂ  ate, and had no evidence of emphysematous 
changes, we next examined elastic ﬁ  bers by staining with 
Hart’s elastin stain (Figure 1, A′ and B′). Assessing and 
representing the integrity of elastic ﬁ  bers in single sections 
is exceptionally difﬁ  cult. Nonetheless, extensive analysis of 
a large number of sections revealed a high density of elastic 
ﬁ  bers with a disorganized appearance, embedded within the 
tissue. Many of the elastic ﬁ  bers displayed a fractured appear-
ance (as represented in Figure 1, B′). To determine whether 
elastin synthesis was ongoing despite the accumulation of 
elastic ﬁ  bers in the tissue, we performed in situ hybridiza-
tion for elastin mRNA on serial sections of tissue (Figure 1, 
A′′ and B′′). This showed that elastin expression is active, 
and localizes to the walls of intralobar arteries, conducting 
airways, and terminal airways and alveoli adjacent to the 
inﬂ  ammatory inﬁ  ltrates. Within an inﬂ  ammatory inﬁ  ltrate 
encompassing a previously patent vessel, elastin expression 
localized to the vessel remnants (Figure 1, B′ and B′′), identi-
ﬁ  ed on the basis of its elastic lamellae and α-smooth muscle 
actin (α-SMA) staining.
Increased smooth muscle 
and myoﬁ  broblasts in CBO
Elastic ﬁ  bers in the lung are largely the product of smooth 
muscle cells of blood vessels and conducting airways and 
myoﬁ  broblasts within alveolar walls. Sections of CBO lung, 
along with normal and emphysematous control lungs, were 
stained for α-SMA to determine whether altered abundance 
or distribution of cells expressing a “myo” phenotype may 
be responsible for the abnormal elastin expression found in 
this adult lung specimen (Figure 2). The typical appearance 
and distribution of elastic ﬁ  bers and alveolar myoﬁ  bro-
blasts in normal adult human lung is shown in Figure 2, A 
and A′. Dense elastic ﬁ  bers localize to alveolar tips, where 
small alveolar myoﬁ  broblasts expressing α-SMA reside. In 
emphysematous lung specimens, some areas exhibit a loss International Journal of COPD 2007:2(4) 596
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of elastic ﬁ  bers associated with enlarged alveolar spaces, 
and the distribution of alveolar myoﬁ  broblasts is altered 
(Figure 2, B and B'). In the CBO lung, alveolar regions had 
dense, enlarged elastic ﬁ  bers localizing to alveolar tips, where 
intensely staining myoﬁ  broblasts were found (Figure 2, 
C and C'). In multiple sections containing areas of extensive 
remodeling in the CBO specimens, dense accumulations of 
disorganized elastic ﬁ  bers were populated by single cells 
and groups of cells staining intensely for α-SMA (Figure 2, 
D/E and D'/E').
Discussion
In the case of cryptogenic CBO described, the root cause of 
the dyspnea and severe airways obstruction was suspected 
to be bronchiolitis, but the pathologic diagnosis was not 
conﬁ  rmed until after lung transplantation. Upon explantation 
of the diseased lung, it was observed that the lung did not 
deﬂ  ate, and that even sections of lung tissue removed for 
pathologic examination remained inﬂ  ated. These unusual 
ﬁ  ndings led to a more detailed analysis of the peripheral 
lung tissue, which was compared to other specimens from 
Figure 1. Abnormal morphology, elastic ﬁ  ber accumulation, and elastin mRNA expression in CBO.  Sections of peripheral lung tissue from CBO-affected lung 
(panels A and B), and control lung (panel C) were ﬁ  xed without inﬂ  ation, embedded, and sectioned at 5 μM.  Serial sections were stained with H and E (A, B, C), for elastic 
ﬁ  bers using Hart’s elastic ﬁ  ber stain (A′, B′, C′), and hybridized in situ for elastin mRNA (A″, B″, C″).  In panel A, a large vessel (top of each panel) is ﬂ  anked by a large airway 
(bottom left of each panel) with accumulation of particulates, visible as black deposits, between the vessel and airway (indicated by white arrow in A and A′). A′ shows elastic 
laminae (stained black) in the intralobar pulmonary artery, and an increased density of elastic ﬁ  bers beneath the epithelium of the large airway and the surrounding lung 
parenchyma compared to control (C′). A″ shows that elastin mRNA expression (black signal) is present in the large blood vessel, conducting airway, and particularly in tissue 
between these structures, and is signiﬁ  cantly increased compared to control lung (C″). Panel B shows a large inﬁ  ltrate (top of panels) ﬂ  anked by surrounding tissue containing 
obliterated airways. Elastin staining in B′ indicates the inﬁ  ltrate likely encompasses an airway, as there is a continuous elastic ﬁ  ber (outlined by white dashed line) indicating a 
luminal structure has been present. Again, elastin density is increased compared to control lung (C’). B″ shows ongoing, intense elastin mRNA expression in tissue surrounding 
the inﬁ  ltrate that is greater than that seen in control lung (C″).
A
A’
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an ongoing study of elastic ﬁ  ber changes in COPD. In marked 
contrast to emphysematous lungs, there was no evidence of 
alveolar septal destruction. In addition, alveolar elastic ﬁ  bers 
were greatly increased in number and density compared to 
normal lung specimens.
The role of elastic ﬁ  bers in CBO has not been well 
characterized. Pulmonary elastin is an extremely stable and 
long-lived polymer (Shapiro et al 1991), and the majority 
of lung elastin expression is limited to the alveolar stage 
of lung development (Parks 1997; Mariani et al 2002). 
Thus, in normal uninjured adult lungs, elastin expression 
is virtually non-existent. Even in lung pathology associated 
with extensive remodeling, ﬁ  brosis due to excess collagen 
deposition is much more common than elastosis. Notably, 
the remodeling of airway walls in CBO is thought to be the 
result of unrestrained collagenous ﬁ  brosis (Markopoulo et al 
2002; Couture and Colby 2003; Visscher and Myers 2006), 
a phenomenon that has been associated with and shown to 
be dependent upon increased transforming growth factor-
beta (TGF-β) signaling (Ramirez et al 2004). A number of 
other genes have been shown to undergo upregulation in 
response to TGF-β signalling, including elastin (Davidson 
et al 1995; Davidson 2002) and alpha smooth muscle actin 
(α-SMA) (Desmouliere et al 1993; Davidson 2002). Most 
cell types expressing elastin in lung development, includ-
ing airway and vascular smooth muscle cells and alveolar 
myoﬁ  broblasts, are positive for α-SMA, and upregulation 
of α-SMA has been implicated in the transition of cells to a 
myoﬁ  broblast phenotype in adults with idiopathic pulmonary 
ﬁ  brosis (Willis et al 2005). For these reasons, we examined 
this case to characterize elastin mRNA expression and the 
abundance of α-SMA-positive cells.
The sampled lung showed evidence of severe CBO, with 
most of the areas demonstrating the phenomenon of ‘disap-
pearing’ bronchioles, an indication of complete bronchiolar 
obliteration by the constrictive process. Elastic ﬁ  bers were 
abundant, dense, thick, and ropy in appearance in the affected 
bronchioles, and in situ hybridization for elastin mRNA 
showed abundant elastin expression localized to the collapsed 
and diseased bronchiolar walls, which were the primary 
sites of excess elastin accumulation. In addition, a similar 
upregulation of elastin deposition was noted in the adjacent 
alveolar areas, and was more extensive than those observed 
in either normal or emphysematous lung specimens.
The combination of upregulated elastin gene expression 
along with myoﬁ  broblast (α-SMA-positive cell) prolifera-
tion, when compared with normal lung, leads us to hypoth-
esize that the elastosis noted in the bronchiolar and alveolar 
Figure 2. Altered distribution and abundance of cells expressing α-SMA in 
CBO lung. Serial sections of lung were stained with Hart’s elastin stain (left panels) 
or for a-SMA (right panels). A: Alveolar section from a control lung specimen showing 
focal elastic ﬁ  bers (black stained) at tips of alveolar walls (grey counterstain). A′: Serial 
section stained for a-SMA shows small alveolar myoﬁ  broblasts localizing to alveolar 
tips. B: Emphysematous lung specimen with diminished complexity, enlarged airspaces, 
and less elastin staining. B′ shows loss of focal staining for a-SMA. C: Alveolar region 
from CBO lung shows large focal elastic ﬁ  bers at alveolar septal tips, and C′ shows 
enlarged myoﬁ  broblasts at the same sites staining intensely for a-SMA. D and E:  
Remodeled regions of CBO lung showing accumulation of thick elastic ﬁ  bers. D′ and 
E′: The elastic ﬁ  bers are surrounded by cells staining intensely for a-SMA.
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walls is likely the result of recent elastin protein synthesis. 
The speciﬁ  c signals leading to increased myoﬁ  broblast abun-
dance and elastin expression are still unknown in this case.
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